Differential effects of dopamine agonists in mature and immature rats

European Journal of Pharmacology
J T McDevitt, P E Setler

Abstract

It has been suggested that because of a relatively slow maturation of the central cholinergic system, that the neonatal rat (i.e. less than 2 weeks old) may be used as an in vivo model, with minimal cholinergic influence, for studying the effects of dopaminergic compounds. d-Amphetamine, 1-DOPA, and SK and F 38393-A produce a syndrome in neonatal rat similar to the stereotyped behavior characteristically produced by dopamine agonists. This neonatal syndrome includes increased motor activity and sniffing plus licking and/or biting. Apomorphine and bromocryptine do not produce this behavior in neonatal rats. The potencies of d-amphetamine, 1-DOPA, and SK and F 38393-A in producing this syndrome decrease with the age of the rat. Increases in motor activity, or sniffing plus licking and/or biting by d-amphetamine 1-DOPA, or SK and F 38393-A, in thirty and/or sixty day old rats are significantly enhanced by scopolamine pretreatment. Apomorphine- or bromocryptine-induced stereotyped behavior in thirty and sixty day old rats is not affected by scopolamine. These data suggest that the effects of certain dopaminergic agonists, which produce the neonatal syndrome, are modulated in the adult rat by cholinergic activity. The ineffectivenes...Continue Reading

References

Sep 1, 1976·Journal of Neurochemistry·J T Coyle, P Campochiaro
Jun 1, 1975·The Journal of Pharmacy and Pharmacology·G BartholiniA Pletscher
Aug 15, 1978·European Journal of Pharmacology·P E SetlerH L Saunders
Sep 1, 1976·European Journal of Pharmacology·P SetlerG McKenzie
Nov 15, 1974·Brain Research·P L McGeerE G McGeer
Jan 1, 1974·Journal of Psychiatric Research·A Randrup, I Munkvad
Jan 1, 1974·European Journal of Pharmacology·T Nose, H Takemoto
Sep 24, 1971·Brain Research·E G McGeerV Wickson
Dec 1, 1967·Life Sciences·H CorrodiU Ungerstedt

❮ Previous
Next ❯

Citations

Sep 12, 1996·European Journal of Pharmacology·G J Shieh, D E Walters
Jan 1, 1983·Progress in Neurobiology·R H FishmanH L Klawans
Jan 1, 1996·Pediatric Neurology·N GrigoriadisO Guiba-Tziampiri
Jan 19, 2016·Frontiers in Behavioral Neuroscience·Susanne NikolausHans-Wilhelm Müller
Jan 8, 2015·Frontiers in Behavioral Neuroscience·Susanne NikolausHans-Wilhelm Müller
Apr 1, 1987·Reviews in the Neurosciences·J L Waddington, K M O'Boyle
Jul 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·R D'AlessandroA Baruzzi
Feb 17, 2006·Journal of Medicinal Chemistry·Antonio Di StefanoFrancesco Pinnen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.